Abstract
The progression of purulent inflammation in any acute surgical abdominal pathology can lead to local or diffuse peritonitis. The parameters characterizing the degree and specificity of the inflammatory response in blood such as cytokine concentration, neutrophil activity, plasma antioxidant capacity (thiols concentration) could be considered as potential predictors of complications. The luminol-dependent chemiluminescence (CL) response of blood activated by the phorbol ester (PMA), levels of cytokines IL-6, IL-8, IL-10, myeloperoxidase (MPO) and thiols were measured in plasma of patients with uncomplicated conditions (group 1, n = 8), local peritonitis (group 2, n = 9) or diffuse peritonitis (group 3, n = 9) at admission (before surgery, b/s), immediately after surgery (a/s) and a day after surgery (1 day) as well as in healthy volunteers (norm, n = 12). At all time-points the concentrations of cytokines and MPO measured by the ELISA method, in group 3 were higher than in healthy volunteers and in patients in groups 1 and 2. Blood CL demonstrated a more than 5-fold increase above the normal values in all patients, and it was also higher in group 2 as compared to group 1. In group 3 there were patients with both maximal and minimal CL values, which could be a consequence of neutrophil priming or exhaustion (“immune paralysis”), respectively. In these patients the plasma thiol content demonstrated a more than 3-fold decrease below normal values. In patients with fatal outcomes (group 3, n = 2) within a day after surgery, either a decrease of the CL to zero values concurrently with elevated IL-8 and IL-6 concentrations and low thiol levels was observed, or CL exceeded normal values more than 20 times with concurrent complete exhaustion of the plasma thiol pool. No clear dependency between the plasma parameters and neutrophil activity was found. This suggests that a panel of parameters for prognosis and/or early diagnostics of infectious complications in acute abdominal pathology should include different biomarkers of the inflammatory response: cytokine profile (IL-6, IL-8, IL-10), MPO and neutrophil activity, antioxidant plasma capacity (e.g., total thiols concentration).
Similar content being viewed by others
REFERENCES
Tolonen, M., Kuuliala, K., Kuuliala, A., Leppänie-mi, A., Kulänpää, M.-L., Sallinen, V., Puolakka-inen, P., and Mentula, P., J. Surg. Res., 2019, vol. 244, pp. 436–443. https://doi.org/10.1016/j.jss.2019.06.081
Hong, C.W., Immune Netw., 2017, vol. 17, no. 5, pp. 298–306. https://doi.org/10.4110/in.2017.17.5.298
Holzer, K., Konietzny, P., Wilhelm, K., and Henrich, D., Eur. Surg. Res., 2002, vol. 34, 275–284. https://doi.org/10.1159/000063071
Holzer, K., Richter, A., Hendrich, D., Wilhelm, K., and Encke, A., Shock, 2001, vol. 15, no. 2, pp. 90–94. https://doi.org/10.1097/00024382-200115020-00002
Guichard, C., Pedruzzi, E., Dewas, C., Fay, M., Pouzet, C., Bens, M., Vandewalle, E.O.D., Gougerot-Pocidalo, M.A., and Elbim, C., J. Biol. Chem., 2005, vol. 280, no. 44, pp. 37021–37032. https://doi.org/10.1074/jbc.M506594200
Quinlan, G.J., Margarson, M.P., Mumby, S., Evans, T.W., and Gutteridge, M.C., Clin. Sci., 1998, vol. 95, pp. 459–465.
Kaysen, G.A., Dubin, J.A., Müller, H.-G., Rosales, L., Levin, N.W., and Mitch, W.E., Kidney International, 2004, vol. 65, no. 4, pp. 1408–1415. https://doi.org/10.1111/j.1523-1755.2004.00520.x
Vlasova, I.I., Mikhalchik, E.V., Gusev, A.A., Balabushevich, N.G., Gusev, S.A., and Kazarinov, K.D., Bioelectromagnetics, 2018, vol. 39, no. 2, pp. 144–155. https://doi.org/10.1002/bem.22103
Sokolov, A.V., Kostevich, V.A., Gorbunov, N.P., Grigorieva, D.V., Gorudko, I.V., Vasilyev, V.B., and Panasenko, O.M., Medical Immunology (Russia), 2018, vol. 20, no. 5, pp. 699–710. https://doi.org/10.15789/1563-0625-2018-5-699-710
Sokolov, A.V., Kostevich, V.A., Zakharova, E.T., Samygina, V.R., Panasenko, O.M., and Vasilyev, V.B., Free Radical Research, 2015, vol. 46, no. 6, pp. 800–811. https://doi.org/10.3109/10715762.2015.1005615
Hu, M.L., Methods Enzymol., 1994, vol. 233, pp. 380–385. https://doi.org/10.1016/s0076-6879(94)33044-1
Schrijver, I.T., Kemperman, H., Roest, M., Kesecioglu, J., and de Lange, D.W., Intensive Care Medicine Experimental, 2017, vol. 5, 43. https://doi.org/10.1186/s40635-017-0157-y
Tanaka, T., Narazaki, M., and Kishimoto, T., Cold Spring Harb. Perspect. Biol., 2014, vol. 6, a016295, https://doi.org/10.1101/cshperspect.a016295
Coopersmith, C.M., Amiot, II, D.M., Strom-berg, P.E., Dunne, W.M., Davis, C.G., Osborne, D.F., Husain, K.D., Turnbull, I.R., Karl, I.E., Hotch-kiss, R.S., and Buchman, T.G., Shock, 2003, vol. 19, no. 5, pp. 408–414. https://doi.org/10.1097/01.shk.0000054370.24363.ee
Ocuin, L.M., Bamboat, Z.M., Balachandran, V.P., Cavnar, M.J., Obaid, H., Plitas, G., and de Matteo, R.P., J. Leuk. Biol., 2011, vol. 89, pp. 423–432. https://doi.org/10.1189/jlb.0810479
Zügel, N., Siebeck, M., Geißler, B., Lichtwark-Aschoff, M., Gippner-Steppert, C., Witte, J., and J-ochum, M., Arch. Surg., 2002, vol. 137, pp. 590–599.
Craciun, F.L., Schuller, E.R., and Remick, D.G., J. Immunol., 2010, vol. 185, pp. 6930–6938. https://doi.org/10.4049/jimmunol.1002300
Vogt, K.L., Summers, C., Chilvers, E.R., and Condliffe, A.M., Eur. J. Clin. Invest., 2018, vol. 48, suppl. 2, e12967. https://doi.org/10.1111/eci.12967
Wright, H.L., Cross, A.L., Edwards, S.W., and Moots, R.J., Rheumatology, 2014, vol. 53, pp. 1321–1331. https://doi.org/10.1093/rheumatology/keu035
Alves-Filho, J.C., Spiller, F., and Cunha, F.Q., Shock, 2010, vol. 34, suppl. 1, pp. 15–21. https://doi.org/10.1097/SHK.0b013e3181e7e61b
Taverna, M., Annals Intensive Care, 2013, vol. 3, 4. https://doi.org/10.1186/2110-5820-3-4
Vlasova, I.I., Mikhalchik, E.V., Barinov, N.A., Kostevich, V.A., Smolina, N.V., Klinov, D.V., and Sokolov, A.V., Nanomedicine: Nanotechnology, Biology Medicine, 2016, vol. 12, pp. 1615–1625. https://doi.org/10.1016/j.nano.2016.02.012
Funding
This work was supported by the Russian Science Foundation (project no. 17-75-30064).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
The study was performed in accordance with international ethical guidelines. Sampling and data processing were performed based on the informed consent of patients and healthy volunteers. The study was approved by the Local Ethics Committee of the Pirogov Russian National Research University (protocol no. 180 of December 17, 2018).
CONFLICT OF INTERESTS
The authors declare that they have no conflicts of interest.
SUPPLEMENTARY INFORMATION
Supplementary materials are available in the electronic version of the article at the journal’s website (pbmc.ibmc.msk.ru).
Additional information
Translated by A. Medvedev
Rights and permissions
About this article
Cite this article
Mikhalchik, E.V., Borodina, I.V., Vlasova, I.V. et al. Biomarkers of Systemic Inflammation in Local and Diffuse Peritonitis. Biochem. Moscow Suppl. Ser. B 15, 125–131 (2021). https://doi.org/10.1134/S1990750821020074
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750821020074